Future of finance: Finance disrupted
Future of finance: Finance disrupted
Innovation in the life sciences finance function
As we edge towards the third decade of the century, business as usual is no longer sufficient to keep up with the pace of innovation and unprecedented changes in the life sciences industry. Amid continuous disruption, the life sciences CFO has an opportunity to take the reins.
How should CFOs respond?
Leading CFOs are focusing on leveraging disruption into opportunities to gain a competitive advantage and grow, while also improving their current operations. Experience shows that CFOs are deriving significant benefits for their organisations by focusing on the following key areas:
- Innovation and investment
- Extreme automation
- Insights and analysis
- Organisation and talent
- Service delivery models
- Risks and controls
What to do next
Life sciences CFOs need to take steps to disrupt their finance functions or face a drain on talent and the abilities to grow revenue and deploy capital effectively. One of the keys to success is creating a blueprint for how the finance organisation can turn disruptions into opportunity.
© 2024 KPMG Huazhen LLP, a People's Republic of China partnership, KPMG Advisory (China) Limited, a limited liability company in Chinese Mainland, KPMG, a Macau (SAR) partnership, and KPMG, a Hong Kong (SAR) partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
The KPMG name and logo are trademarks used under license by the
independent member firms of the KPMG global organisation.
For more detail about the structure of the KPMG global organisation please visit https://kpmg.com/governance.